À retenir
Among 4425 cognitively unimpaired adults aged 65 to 85, each additional hour of self-reported nighttime sleep was associated with a 0.005 lower global β-amyloid standardized uptake value ratio (P = .03), while daytime sleep was linked to higher amyloid in some regions. The effects are small and cross-sectional, so they cannot show that sleep changes amyloid rather than the reverse.
Study design
Étude transversale
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sleep often becomes disrupted as neurodegenerative disease progresses, but it is unclear how large the link is and when it starts, before any cognitive impairment. The authors tested how daytime and nighttime sleep duration relate to regional β-amyloid, a hallmark protein of early Alzheimer disease, in older adults.
Population et méthode
Cross-sectional analysis of screening data collected between April 1, 2014 and December 31, 2017 for the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease (A4) Study. Participants were healthy adults aged 65 to 85 with florbetapir F 18 PET, APOE genotype, a Mini-Mental State Examination score of 25 to 30 and a Clinical Dementia Rating of 0. The exposures were self-reported daytime and nighttime sleep duration, and the outcome was regional β-amyloid on PET (standardized uptake value ratio). Data were analysed from December 1, 2019 to May 10, 2021.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The 4425 participants had a mean (SD) age of 71.3 (4.7) years; 2628 (59.4%) were female and 1509 (34.1%) tested β-amyloid positive.
- 2Each additional hour of nighttime sleep was associated with lower amyloid: 0.005 lower global (P = .03), 0.009 lower in the medial orbitofrontal region (P < .001) and 0.011 lower in the anterior cingulate (P < .001).
- 3Among amyloid-negative participants, an extra hour of nighttime sleep was associated with 0.006 lower medial orbitofrontal amyloid (P < .001) and 0.005 lower anterior cingulate amyloid (P = .03).
- 4In amyloid-negative participants, daytime sleep was associated with higher amyloid: 0.013 higher in the precuneus (P = .03) and 0.024 higher in the posterior cingulate (P = .001). The authors say daytime sleep did not appear to make up for lost nighttime sleep.
Limites et incertitude
- 1Sleep duration was self-reported, which is less accurate than measured sleep.
- 2Cross-sectional data capture one time point, so they cannot show whether short sleep leads to amyloid buildup or early amyloid disrupts sleep.
- 3The differences are small (a few thousandths of a ratio unit per hour), and the abstract does not give confidence intervals or say how much they matter clinically.
- 4The A4 screening sample is selected volunteers interested in a prevention trial, so it may not represent all older adults. This reading is based on the abstract only.
Mise en perspective
The study fits the idea that regular, sufficient nighttime sleep may be good for the ageing brain, but the associations are small and cannot prove cause. It does not tell anyone to nap less or to sleep more to prevent Alzheimer disease. Persistent sleep problems or memory worries are worth discussing with a clinician.
Vos données
Wearables can show your nighttime sleep duration and any daytime naps, but they estimate sleep and cannot measure amyloid, so there is no brain-health score to read from them. Use the same device and compare weekly averages of nighttime sleep rather than single nights.
Comprendre ce type de preuve
Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Importance
Disrupted sleep commonly occurs with progressing neurodegenerative disease. Large, well-characterized neuroimaging studies of cognitively unimpaired adults are warranted to clarify the magnitude and onset of the association between sleep and emerging β-amyloid (Aβ) pathology.
Objective
To evaluate the associations between daytime and nighttime sleep duration with regional Aβ pathology in older cognitively unimpaired adults.
Design, setting, and participants
In this cross-sectional study, screening data were collected between April 1, 2014, and December 31, 2017, from healthy, cognitively unimpaired adults 65 to 85 years of age who underwent florbetapir F 18 positron emission tomography (PET), had APOE genotype information, scored between 25 and 30 on the Mini-Mental State Examination, and had a Clinical Dementia Rating of 0 for the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease (A4) Study. Data analysis was performed from December 1, 2019, to May 10, 2021.
Exposures
Self-reported daytime and nighttime sleep duration.
Main outcomes and measures
Regional Aβ pathology, measured by florbetapir PET standardized uptake value ratio.
Results
Amyloid PET and sleep duration information was acquired on 4425 cognitively unimpaired participants (mean [SD] age, 71.3 [4.7] years; 2628 [59.4%] female; 1509 [34.1%] tested Aβ positive). Each additional hour of nighttime sleep was associated with a 0.005 reduction of global Aβ standardized uptake value ratio (F1, 4419 = 5.0; P = .03), a 0.009 reduction of medial orbitofrontal Aβ (F1, 4419 = 17.4; P < .001), and a 0.011 reduction of anterior cingulate Aβ (F1, 4419 = 15.9; P < .001). When restricting analyses to participants who tested Aβ negative, nighttime sleep was associated with a 0.006 reduction of medial orbitofrontal Aβ (F1,2910 = 16.9; P < .001) and a 0.005 reduction of anterior cingulate Aβ (F1,2910 = 7.6; P = .03). Daytime sleep was associated with a 0.013 increase of precuneus Aβ (F1,2910 = 7.3; P = .03) and a 0.024 increase of posterior cingulate Aβ (F1,2910 = 14.2; P = .001) in participants who tested Aβ negative.
Conclusions and relevance
In this cross-sectional study, the increased risk of Aβ deposition with reduced nighttime sleep duration occurred early, before cognitive impairment or significant Aβ deposition. Daytime sleep may be associated with an increase in risk for early Aβ accumulation and did not appear to be corrective for loss of nighttime sleep, demonstrating a circadian rhythm dependence of sleep in preventing Aβ accumulation. Treatments that improve sleep may reduce early Aβ accumulation and aid in delaying the onset of cognitive dysfunction associated with early Alzheimer disease.
Sources et attribution
Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults.
Insel PS, Mohlenhoff BS, Neylan TC, Krystal AD, Mackin RS.
JAMA network open · 2021-07-01
DOI: 10.1001/jamanetworkopen.2021.17573 ↗PubMed · 34297074 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

